The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Equities research analysts at William Blair lowered their Q2 2026 earnings per share estimates for Zumiez in a report ...

Stock analysts at William Blair issued their Q1 2026 earnings per share estimates for Allbirds in a research report issued on ...

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

William Blair downgraded Udemy (UDMY) to Market Perform from Outperform after the company announced the appointment of Hugo Sarrazin as ...

Baer also told analysts that Stitch Fix customers span all income levels, and that most U.S. shoppers are unhappy with the current in-store shopping experience for clothing. The executive cited market ...

Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Magic Software Enterprises (NasdaqGS:MGIC) ...

Tony Blair was elected Prime Minister in a landslide victory for Labour on May 2, 1997. It ended 18 years of Tory rule.

The note emphasized that Palantir shares declined 10% following a 4% selloff in the Nasdaq, and if the broader market ...

William Blair analyst Louie DiPalma maintained a Hold rating on Palantir Technologies (PLTR – Research Report) today. The company’s shares ...

CMS approves ADLT status for Guardant Health's Shield test, setting Medicare reimbursement at $1,495. The analyst sees a ...